Antiverse's Biz Plan Competition Round

Antiverse raised a round of funding on July 16, 2018. Investors include Accelerate@Babraham.

Antiverse is building a world-first computational antibody drug discovery platform. It combines in-house lab expertise with state-of-the-art machine learning to predict antibody-antigen binding and pr…

Articles about Antiverse's Biz Plan Competition Round: